Grifols (GRFS) Total Assets (2009 - 2026)
Grifols (GRFS) total assets from Dec 31, 2009 to Mar 31, 2026. The current Grifols (GRFS) total assets is $23B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Total Assets
Total Assets
Grifols (GRFS) Total Assets CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +1.86% |
| 3 Years TTM | +0.66% |
| 5 Years TTM | +4.85% |
| 10 Years TTM | +8.46% |
| All Time TTM | +20.01% |
Annual Total Assets change of Grifols (GRFS)
| Year | Total Assets | Change |
|---|---|---|
| 2025 | $23B | +4.68% |
| 2024 | $22B | -4.42% |
| 2023 | $23B | +2.39% |
| 2022 | $23B | +3.58% |
| 2021 | $22B | +17.18% |
| 2020 | $19B | -4.63% |
| 2019 | $20B | +36.74% |
| 2018 | $14B | +9.05% |
| 2017 | $13B | +23.79% |
| 2016 | $11B | +1.65% |
| 2015 | $10B | +2.01% |
| 2014 | $10B | +27.34% |
| 2013 | $8.03B | +8.11% |
| 2012 | $7.42B | -1.16% |
| 2011 | $7.51B | +197.05% |
| 2010 | $2.53B | +6.52% |
| 2009 | $2.37B | +43.96% |
| 2008 | $1.65B | +20.34% |
| 2007 | $1.37B | N/A |
Comparison Grifols (GRFS) total assets with competitors
Grifols (GRFS) total assets is $23.22B.
| Ticker | Name | Total Assets | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | $559.22B | +2308.54% |
| PFE | Pfizer Inc | $207.62B | +794.20% |
| JNJ | Johnson & Johnson | $200.89B | +765.24% |
| ABBV | Abbvie Inc | $136.46B | +487.74% |
| MRK | Merck & Co Inc | $128.69B | +454.24% |
| SNY | Sanofi | $128.02B | +451.39% |
| NVS | Novartis AG | $118.53B | +410.51% |
| LLY | Lilly(Eli) & Company | $116.58B | +402.09% |
| AZN | Astrazeneca plc | $114.02B | +391.06% |
| AMGN | AMGEN Inc | $92.50B | +298.41% |
| BMY | Bristol-Myers Squibb Company | $86.48B | +272.45% |
| GSK | GSK Plc | $82.91B | +257.07% |
| GILD | Gilead Sciences Inc | $56.28B | +142.39% |
| BIIB | Biogen Inc | $29.48B | +26.98% |
| OGN | Organon & Company | $13.00B | -44.03% |
| AMRN | Amarin Corp | $645.76M | -97.22% |
| SCLX | Scilex Holding Company | $293.63M | -98.74% |
| MIRA | Mira Pharmaceuticals Inc | $9.46M | -99.96% |
| MDCX | MDCorp | $7.43M | -99.97% |
| MDCXW | Medicus Pharma Ltd warrant | $7.43M | -99.97% |
| NSRX | Nasus Pharma Ltd | $5.00M | -99.98% |